| Followers | 230 |
| Posts | 15196 |
| Boards Moderated | 0 |
| Alias Born | 03/30/2005 |
Tuesday, September 29, 2020 11:42:30 AM
This is why the Pr's are followed by a safe harbor statement. There has never been a firm date given only suggestions and even hints at excess drug based upon the current trial design
the above is all IMHO (consider this my safe harbor statement)
Recent IPIX News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
